So wonderful to read through the BASSER Progress report! Gives me such hope for our children’s future.
IN 10 YEARS
By 2030, Basser will continue to improve our understanding of BRCA, allowing us to overcome chemotherapy resistance, develop new targeted therapies for mutation carriers, and have better medications for managing metastatic breast cancer. We also plan to have more data on the effectiveness of removing just the fallopian tubes as a preventative measure for ovarian cancer, offering patients protection without triggering menopause and its myriad side effects.
IN 15 YEARS
By the year 2035, Basser Center hopes to have an FDA-approved medication or vaccine to prevent BRCA1/2-related cancers— not just breast cancer, but ovarian, prostate, and pancreatic cancer, too.